Literature DB >> 34079705

Feasibility of dual-phase 99mTc-MDP SPECT/CT imaging in rheumatoid arthritis evaluation.

Yasser G Abdelhafez1,2, Felipe Godinez1,3, Kanika Sood4, Rosalie J Hagge1, Robert D Boutin1,5, Siba P Raychaudhuri4,6, Ramsey D Badawi1, Abhijit J Chaudhari1.   

Abstract

BACKGROUND: To prospectively demonstrate the feasibility of performing dual-phase SPECT/CT for the assessment of the small joints of the hands of rheumatoid arthritis (RA) patients, and to evaluate the reliability of the quantitative and qualitative measures derived from the resulting images.
METHODS: A SPECT/CT imaging protocol was developed in this pilot study to scan both hands simultaneously in participants with RA, in two phases of 99mTc-MDP radiotracer uptake, namely the soft-tissue blood pool phase (within 15 minutes after radiotracer injection) and osseous phase (after 3 hours). Joints were evaluated qualitatively (normal vs. abnormal uptake) and quantitatively [by measuring a newly developed metric, maximum corrected count ratio (MCCR)]. Qualitative and quantitative evaluations were repeated to assess reliability.
RESULTS: Four participants completed seven studies (all four were imaged at baseline, and three of them at follow-up after 1-month of arthritis therapy). A total of 280 joints (20 per hand) were evaluated. The MCCR from soft-tissue phase scans was significantly higher for clinically abnormal joints compared to clinically normal ones; P<0.001, however the MCCR from the osseous phase scans were not different between the two joint groups. Intraclass Correlation Coefficient (ICC) for MCCR was excellent [0.9789, 95% confidence interval (CI): 0.9734-0.9833]. Intra-observer agreement for qualitative SPECT findings was substantial for both the soft-tissue phase (kappa =0.78, 95% CI: 0.72-0.83) and osseous-phase (kappa =0.70, 95% CI: 0.64-0.76) scans.
CONCLUSIONS: Extracting reliable quantitative and qualitative measures from dual-phase 99mTc-MDP SPECT/CT hand scans is feasible in RA patients. SPECT/CT may provide a unique means for assessing both synovitis and osseous involvement in RA joints using the same radiotracer injection. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Bone scan; SPECT/CT; osteoblastic response; rheumatoid arthritis; soft tissue vascularity

Year:  2021        PMID: 34079705      PMCID: PMC8107345          DOI: 10.21037/qims-20-996

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  36 in total

Review 1.  The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.

Authors:  P P Tak; B Bresnihan
Journal:  Arthritis Rheum       Date:  2000-12

Review 2.  Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.

Authors:  Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2012-07       Impact factor: 7.580

3.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

Review 4.  Clinical applications of SPECT/CT in imaging the extremities.

Authors:  Martin W Huellner; Klaus Strobel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-21       Impact factor: 9.236

5.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

6.  Early and Delayed 99mTc-MDP SPECT/CT Findings in Rheumatoid Arthritis and Osteoarthritis.

Authors:  Yasser G Abdelhafez; Rosalie J Hagge; Ramsey D Badawi; Siba P Raychaudhuri; Abhijit J Chaudhari
Journal:  Clin Nucl Med       Date:  2017-11       Impact factor: 7.794

7.  Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Authors:  K L Hyrich; K D Watson; A J Silman; D P M Symmons
Journal:  Rheumatology (Oxford)       Date:  2006-05-16       Impact factor: 7.580

8.  Synovitis and bone inflammation in early rheumatoid arthritis: high-resolution multi-pinhole SPECT versus MRI.

Authors:  Christian Buchbender; Benedikt Ostendorf; Katalin Mattes-György; Falk Miese; Hans-Joerg Wittsack; Michael Quentin; Christof Specker; Matthias Schneider; Gerald Antoch; Hans-Wilhelm Müller; Axel Scherer
Journal:  Diagn Interv Radiol       Date:  2012-12-13       Impact factor: 2.630

Review 9.  Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials.

Authors:  Monica S M Persson; Aliya Sarmanova; Michael Doherty; Weiya Zhang
Journal:  Rheumatology (Oxford)       Date:  2018-10-01       Impact factor: 7.580

10.  The EANM practice guidelines for bone scintigraphy.

Authors:  T Van den Wyngaert; K Strobel; W U Kampen; T Kuwert; W van der Bruggen; H K Mohan; G Gnanasegaran; R Delgado-Bolton; W A Weber; M Beheshti; W Langsteger; F Giammarile; F M Mottaghy; F Paycha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-04       Impact factor: 9.236

View more
  1 in total

Review 1.  Imaging of Synovial Inflammation in Osteoarthritis, From the AJR Special Series on Inflammation.

Authors:  Jacob Thoenen; James W MacKay; Halston J C Sandford; Garry E Gold; Feliks Kogan
Journal:  AJR Am J Roentgenol       Date:  2021-07-21       Impact factor: 3.959

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.